The future of HIV vasculopathy when our patients are on antiretroviral therapy
Barry, R.
SouthAfricanJournalofSurgery.Suid-AfrikaanseTydskrifVirChirurgie 47(2): 5860
2009
ISSN/ISBN: 0038-2361 PMID: 19626782 Document Number: 628324
South Africa was one of the last countries in Africa to be affected by the HIV epidemic, but currently has one of the highest prevalences in the world. Antiretroviral therapy (ART) was recently introduced in South Africa, and as of December 2007 antiretroviral treatment coverage in this country was about 25% (UNAIDS, 2008). There is a well-documented relationship between vascular disease and HIV infection. This HIV vasculopathy may manifest as arterial aneurysms, occlusive disease or complications of hypercoagulability. The question to be asked is 'What is the future of HIV vasculopathy when our patients are on antiretroviral therapy?'
Document emailed within 1 workday
Related Documents
Sharma, S.; Khadga, P.; Dhungana, G.P.; Chitrakar, U. 2013: Medication adherence to antiretroviral therapy among patients visiting antiretroviral therapy center at Tribhuvan University Teaching Hospital, Kathmandu Nepal Kathmandu University Medical Journal 11(41): 50-53Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Hata, M.; Mandai, M.; Kojima, H.; Kameda, T.; Miyamoto, N.; Kurimoto, Y. 2012: Five-year visual outcomes of typical age-related macular degeneration and/or polypoidal choroidal vasculopathy patients who received photodynamic therapy (PDT) as initial treatment in comparison with patients prior to the PDT era Nippon Ganka Gakkai Zasshi 116(10): 937-945
Humphreys, E.H.; Chang, L.W.; Harris, J. 2010: Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy Cochrane Database of Systematic Reviews 6: Cd006517
Rajesh, L.; Karunaianantham, R.; Narayanan, P.R.; Swaminathan, S. 2009: Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients Aids Research and Human Retroviruses 25(11): 1179-1185
Tan, R.; Westfall, A.O.; Willig, J.H.; Mugavero, M.J.; Saag, M.S.; Kaslow, R.A.; Kempf, M.C. 2008: Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 47(5): 553-558
Newman, H.; Breunig, L.; van Zyl, G.; Stich, A.; Preiser, W. 2014: A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 60(4): 387-391
Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Alvi, Y.; Khalique, N.; Ahmad, A.; Khan, H.S.; Faizi, N. 2019: World Health Organization Dimensions of Adherence to Antiretroviral Therapy: a Study at Antiretroviral Therapy Centre, Aligarh Indian Journal of Community Medicine: Official Publication of Indian Association of Preventive and Social Medicine 44(2): 118-124
Meintjes, G.; Black, J.; Conradie, F.; Dlamini, S.; Maartens, G.; Manzini, T.C.; Mathe, M.; Moorhouse, M.; Moosa, Y.; Nash, J.; Orrell, C.; Venter, F.; Wilson, D. 2015: Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: Update on when to initiate antiretroviral therapy Southern African journal of HIV medicine 16(1): 428
Muhamadi, L.; Nsabagasani, X.; Tumwesigye, M.Nazarius.; Wabwire-Mangen, F.; Ekström, A-Mia.; Peterson, S.; Pariyo, G. 2010: Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD<350 cells/microL) in eastern Uganda Health Policy 97(2-3): 187-194
Mahy, M.; Lewden, C.; Brinkhof, M.W.G.; Dabis, F.; Tassie, J.-M.; Souteyrand, Y.; Stover, J. 2010: Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy Sexually Transmitted Infections 86(Suppl 2): Ii28-Ii34
Iurin, O.G. 2007: Indications for initiation of antiretroviral therapy in patients with HIV infection. Choice of first-line drugs and schemes of therapy Terapevticheskii Arkhiv 79(11): 67-69
Peñagarícano, J.é A.; Linskey, M.E.; Ratanatharathorn, V. 2004: Accelerated cerebral vasculopathy after radiation therapy to the brain Neurology India 52(4): 482-486
Umpleby, A.M.; Das, S.; Stolinski, M.; Shojaee-Moradie, F.; Jackson, N.C.; Jefferson, W.; Crabtree, N.; Nightingale, P.; Shahmanesh, M. 2005: Low density lipoprotein apolipoprotein B metabolism in treatment-naive HIV patients and patients on antiretroviral therapy Antiviral Therapy 10(5): 663-670
Geng, E.H.; Glidden, D.V.; Emenyonu, N.; Musinguzi, N.; Bwana, M.B.; Neilands, T.B.; Muyindike, W.; Yiannoutsos, C.T.; Deeks, S.G.; Bangsberg, D.R.; Martin, J.N. 2010: Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa Tropical Medicine and International Health: Tm and Ih 15(Suppl 1): 63-69
Smith, K.Y.; Virgil, L.A. 2004: Initiating antiretroviral therapy in asymptomatic HIV patients Journal of the National Medical Association 96(2 Suppl): 13s-16s
Yu, J.K.-L.; Tok, T.-S.; Tsai, J.-J.; Chang, W.-S.; Dzimadzi, R.K.; Yen, P.-H.; Makombe, S.D.; Nkhata, A.; Schouten, E.J.; Kamoto, K.; Harries, A.D. 2008: What happens to patients on antiretroviral therapy who transfer out to another facility? Plos one 3(4): E2065
Pal, J.; Sen, K.; Sarkar, G.; Mandal, A.; Chakraborty, S.; Deb, A. 2013: Effect of antiretroviral therapy on pulmonary hypertension in HIV patients Journal of the Indian Medical Association 111(12): 845